Arovella Therapeutics Ltd
(FRA:E4NA)
€
0.0875
0.003 (3.55%)
Market Cap: 98.86 Mil
Enterprise Value: 96.75 Mil
PE Ratio: 0
PB Ratio: 14.09
GF Score: 36/100 - Arovella Therapeutics Ltd at TechKnow Investor Conference - Melbourne TranscriptAug 03, 2023
- Arovella Therapeutics Ltd Webinar Presentation TranscriptJun 22, 2023
- Arovella Therapeutics Ltd AACR Conference TranscriptApr 19, 2023
- Arovella Therapeutics Ltd Webinar Presentation TranscriptApr 04, 2023
- Suda Pharmaceuticals Ltd at NWR Communications Investor Conference (Virtual) TranscriptAug 03, 2021
Arovella Therapeutics Ltd Webinar Presentation Transcript
Jun 22, 2023 / 01:00AM GMT
Release Date Price:
€0.0225
(-8.16%)
Operator
Presentation
Jun 22, 2023 / 01:00AM GMT
=====================
Corporate Participants
=====================
* Michael Baker
Arovella Therapeutics Limited - CEO & MD
=====================
Michael Baker
Arovella Therapeutics Limited - CEO & MD
Thank you for standing by, and welcome to the Arovella Therapeutics investor webinar and Q&A today. (Operator instructions) But appearing on behalf of the Arovella today, we have the CEO and Managing Director, Dr. Michael Baker. Michael, I'll hand it over to you.
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)